Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.58 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.49 |
| ▸ | AR | P10275 | 1/20 | 0.49 |
| ▸ | HCAR3 | P49019 | 4/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL351553 | 0.87 | CASP6 (0.57) | PTPN1CASP6ALDH1A1TSHRLMNA | |
| SCHEMBL23909599 | 0.86 | ALDH1A1 (0.54) | CASP6ALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL23909575 | 0.86 | ALDH1A1 (0.54) | PTPN1CASP6ALDH1A1TSHRMEN1 | |
| SCHEMBL7243262 | 0.82 | MEN1 (0.62) | CASP6ALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL18640132 | 0.82 | AKR1C4 (0.54) | ALDH1A1LMNAMEN1KMT2AAKR1C4 | |
| Methyl Alcohol SCHEMBL8967197 | 0.79 | MEN1 (0.59) | CASP6ALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL30399151 | 0.79 | CDK2 (0.55) | PTPN1CASP6ALDH1A1TSHRMEN1 | |
| SCHEMBL8960516 | 0.79 | CASP6 (0.64) | CASP6TSHRLMNAMEN1KMT2A | |
| SCHEMBL30714879 | 0.79 | CASP6 (0.64) | CASP6TSHRLMNAMEN1KMT2A | |
| SCHEMBL772810 | 0.79 | CDK2 (0.55) | PTPN1CASP6ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100497441-C | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2009-06-10 | — | — | CN | claimed |
| CN-1289504-C | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1616521-A | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1616462-A | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | claimed |
| WO-2023209342-A1 | METHOD AND APPARATUS FOR CARBON DIOXIDE SEPARATION | MOF Technologies Limited (GB) | 2023-11-02 | — | — | WO | disclosed |
| US-20220267268-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | ANAMAR AB (SE) | 2022-08-25 | — | — | US | disclosed |
| CN-114616224-A | Novel tricyclic 5-HT2Antagonists | 安娜玛有限公司 | 2022-06-10 | — | — | CN | disclosed |
| EP-3986865-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | AnaMar AB (SE) | 2022-04-27 | — | — | EP | disclosed |
| CN-109642094-B | Composite material | 巴斯夫欧洲公司 | 2021-09-14 | — | — | CN | disclosed |
| WO-2020254322-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | ANAMAR AB (SE) | 2020-12-24 | — | — | WO | disclosed |
| CN-105579128-B | The method that recycling forms the component of metal-organic framework materials | 巴斯夫欧洲公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-107074429-B | Sorbent materials for extended produce (product) shelf life | 巴斯夫公司 | 2019-08-09 | — | — | CN | disclosed |
| WO-2014191725-A1 | PROCESS FOR THE PREPARATION OF A METAL-ORGANIC COMPOUND | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2014-12-04 | — | — | WO | disclosed |
| WO-2014078328-A1 | N-BICYCLIC ARYL,N'-PYRAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| CN-100497441-C | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2009-06-10 | — | — | CN | disclosed |
| CN-1289504-C | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2006-12-13 | — | — | CN | disclosed |
| CN-1616521-A | Polyimide containing isoscrbierite unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | disclosed |
| CN-1616462-A | Diamine monomer containing di-dehydrated hexitol unit and its preparing method | UNIV TSINGHUA (CN) | 2005-05-18 | — | — | CN | disclosed |
| US-4490370-A | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0122155-A2 | Improvements in or relating to naphthylglycyl cephalosporin derivatives | ELI LILLY AND COMPANY (US) | 1984-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267268-A1 | NEW TRICYCLIC 5-HT2 ANTAGONISTS | HTR2B, HTR2C, TPH2 | PTPN1 2112/4885CASP6 3967/4885ALDH1A1 1862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.